Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00574665 · ClinicalTrials.gov registry record · NA

Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 1

A NA study of Type 2 Diabetes, sponsored by Vanderbilt University.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT00574665 is a NA study of Type 2 Diabetes that has completed, run by Vanderbilt University. The registered enrollment target is 32 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00574665, a NA study of Type 2 Diabetes, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to learn more about why patients with diabetes have increased heart attacks, strokes and other illnesses due to blood clots causing blockage of a blood vessel. The proposed protocol will study the separate and combined effects of hyperglycemia and hyperinsulinemia on endothelial function and fibrinolytic balance in Type 2 DM. Our hypothesis is that hyperglycemia, rather than hyperinsulinemia, is responsible for the dysregulation of fibrinolytic balance in diabetics.

Conditions Studied

Type 2 Diabetes

Interventions

  • OTHER Hyperinsulinemic Hyperglycemic Clamp

Study Locations (1)

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2006-10
Est. Completion 2010-12
Phase NA

Sponsor

Vanderbilt University

430 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00574665

The ClinicalTrials.gov registry entry for NCT00574665 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Hyperinsulinemic Hyperglycemic Clamp is the first listed.

NCT00574665 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00574665 about?

NCT00574665 is a clinical study titled "Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 1". The purpose of this study is to learn more about why patients with diabetes have increased heart attacks, strokes and other illnesses due to blood clots causing blockage of a blood vessel. The proposed protocol will study the separate and combined effects of hyperglycemia and hyperinsulinemia on end...

What is the current status of trial NCT00574665?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2006-10. Estimated completion is 2010-12.

What conditions does trial NCT00574665 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT00574665?

The interventions under investigation include: Hyperinsulinemic Hyperglycemic Clamp (OTHER).

Who is sponsoring clinical trial NCT00574665?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00574665 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 2 Diabetes

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.